Advertisement

Latest News

AIRCULES: Lunsekimig Benefit Scales With Severity, With Njira Lugogo, MD

2 hours ago

Phase 2b subgroup data showed lunsekimig's exacerbation benefit scaled with asthma severity and biomarker levels.

Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD

2 hours ago

A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.

STAT6 Degraders: Accessible Biologic-Like Asthma Care? With Njira Lugogo, MD

3 hours ago

Lugogo, ofUniversity of Michigan, discusses how oral STAT6 degraders like KT-621 could expand biologic-like asthma treatment beyond highest severity.

LEADderm 2026 Recap: 7 Interviews Dermatologists Should Know

3 hours ago

A recap of 7 standout interviews from LEADderm 2026, covering molluscum care, HS pipeline data, precision medicine, and dermatology leadership.

ADHERE-ASCVD: Digital Reminders Improve Refill Rates, Adherence to Statins in ASCVD

4 hours ago

Ankeet Bhatt, MD, MBA, discusses the effectiveness of text, email, and secure portal message reminders for encouraging patients to keep up with their treatment.

Advertisement
Advertisement